Home・Список акций・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Закрыт

СекторЗдравоохранение

575.5 -0.21

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

562.67

Макс.

577.21

Ключевые показатели
By Trading Economics
Доход	85M 1.7B
Продажи	989M 12B
P/E Средняя по отрасли	30.575 64.641
Прибыль на акцию	6.03
Дивидендная доходность	0.15
Рентабельность продаж	14.516
Сотрудники	125,000
EBITDA	262M 2.6B

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+6.98% upside

Дивиденды
By Acuity
Дивидендная доходность Средняя по отрасли	0.15% 2.31%
Следующий отчет о доходах	21 окт. 2026 г.
Дата следующей выплаты дивидендов	15 окт. 2026 г.
Следующая эксдивидендная дата	15 сент. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	17B 213B
Предыдущая цена открытия	575.71
Предыдущая цена закрытия	575.5

Новостные настроения

By Acuity

23%

77%

66 / 340 Рейтинг в Healthcare

Thermo Fisher Scientific Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

31 июл. 2026 г., 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30 июл. 2026 г., 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29 июл. 2026 г., 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28 июл. 2026 г., 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27 июл. 2026 г., 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24 июл. 2026 г., 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23 июл. 2026 г., 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22 июл. 2026 г., 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21 июл. 2026 г., 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20 июл. 2026 г., 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Сравнение c конкурентами

Изменение цены

Thermo Fisher Scientific Inc Прогноз

Целевая цена

By TipRanks

6.98% рост

Прогноз на 12 месяцев

Средняя 614.41 USD 6.98%

Максимум 690 USD

Минимум 520 USD

Основано на мнении 19 аналитиков Wall Street, спрогнозировавших целевые цены для Thermo Fisher Scientific Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

19 ratings

Покупка

Удержание

Продажа

Основано на мнении 19 аналитиков, присваивавших рейтинги акциям Thermo Fisher Scientific Inc – Данные за последние 3 месяца.

Настроения

By Acuity

66 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar